304 related articles for article (PubMed ID: 35563548)
21. The evolving role of the endocannabinoid system in gynaecological cancer.
Ayakannu T; Taylor AH; Willets JM; Konje JC
Hum Reprod Update; 2015; 21(4):517-35. PubMed ID: 25958409
[TBL] [Abstract][Full Text] [Related]
22. Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome.
Brierley SM; Greenwood-Van Meerveld B; Sarnelli G; Sharkey KA; Storr M; Tack J
Nat Rev Gastroenterol Hepatol; 2023 Jan; 20(1):5-25. PubMed ID: 36168049
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoids and appetite: food craving and food pleasure.
Kirkham TC
Int Rev Psychiatry; 2009 Apr; 21(2):163-71. PubMed ID: 19367510
[TBL] [Abstract][Full Text] [Related]
24. [The endocannabinoid system in obesity].
Pataky Z; Bobbioni-Harsch E; Carpentier A; Golay A
Rev Med Suisse; 2013 Mar; 9(379):653-4, 656-7. PubMed ID: 23596738
[TBL] [Abstract][Full Text] [Related]
25. Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System-Implications for Health and Disease.
Moreno E; Cavic M; Canela EI
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33915889
[TBL] [Abstract][Full Text] [Related]
26. Roles of Endocannabinoids and Endocannabinoid-Like Molecules in Energy Homeostasis and Metabolic Regulation: A Nutritional Perspective.
Rahman SMK; Uyama T; Hussain Z; Ueda N
Annu Rev Nutr; 2021 Oct; 41():177-202. PubMed ID: 34115519
[TBL] [Abstract][Full Text] [Related]
27. The endocannabinoid system and related lipids as potential targets for the treatment of migraine-related pain.
Greco R; Demartini C; Zanaboni AM; Francavilla M; De Icco R; Ahmad L; Tassorelli C
Headache; 2022 Mar; 62(3):227-240. PubMed ID: 35179780
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoids in Metabolic Syndrome and Cardiac Fibrosis.
Navarrete C; Garcia-Martin A; DeMesa J; Muñoz E
Curr Hypertens Rep; 2020 Oct; 22(12):98. PubMed ID: 33089434
[TBL] [Abstract][Full Text] [Related]
29. Dietary PUFAs and Exercise Dynamic Actions on Endocannabinoids in Brain: Consequences for Neural Plasticity and Neuroinflammation.
Park Y; Watkins BA
Adv Nutr; 2022 Oct; 13(5):1989-2001. PubMed ID: 35675221
[TBL] [Abstract][Full Text] [Related]
30. The role of endocannabinoids in the hypothalamic regulation of visceral function.
Wenger T; Moldrich G
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):301-7. PubMed ID: 12052044
[TBL] [Abstract][Full Text] [Related]
31. The role of the endocannabinoid system in female reproductive tissues.
Walker OS; Holloway AC; Raha S
J Ovarian Res; 2019 Jan; 12(1):3. PubMed ID: 30646937
[TBL] [Abstract][Full Text] [Related]
32. Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood.
Fride E; Bregman T; Kirkham TC
Exp Biol Med (Maywood); 2005 Apr; 230(4):225-34. PubMed ID: 15792943
[TBL] [Abstract][Full Text] [Related]
33. Emerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models.
Morales P; Reggio PH
Adv Exp Med Biol; 2021; 1264():47-65. PubMed ID: 33332003
[TBL] [Abstract][Full Text] [Related]
34. The emerging role of the endocannabinoid system in endocrine regulation and energy balance.
Pagotto U; Marsicano G; Cota D; Lutz B; Pasquali R
Endocr Rev; 2006 Feb; 27(1):73-100. PubMed ID: 16306385
[TBL] [Abstract][Full Text] [Related]
35. The Role of Cannabinoids in Allergic Diseases: Collegium Internationale Allergologicum (CIA) Update 2020.
Angelina A; Pérez-Diego M; López-Abente J; Palomares O
Int Arch Allergy Immunol; 2020; 181(8):565-584. PubMed ID: 32526734
[TBL] [Abstract][Full Text] [Related]
36. Hemopressin Peptides as Modulators of the Endocannabinoid System and their Potential Applications as Therapeutic Tools.
Macedonio G; Stefanucci A; Maccallini C; Mirzaie S; Novellino E; Mollica A
Protein Pept Lett; 2016; 23(12):1045-1051. PubMed ID: 27748182
[TBL] [Abstract][Full Text] [Related]
37. The endocannabinoid system and energy metabolism.
Bellocchio L; Cervino C; Pasquali R; Pagotto U
J Neuroendocrinol; 2008 Jun; 20(6):850-7. PubMed ID: 18601709
[TBL] [Abstract][Full Text] [Related]
38. Endocannabinoids and liver disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis.
Kunos G; Osei-Hyiaman D
Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1101-4. PubMed ID: 18292184
[TBL] [Abstract][Full Text] [Related]
39. Endocannabinoid system: An overview of its potential in current medical practice.
Mouslech Z; Valla V
Neuro Endocrinol Lett; 2009; 30(2):153-79. PubMed ID: 19675519
[TBL] [Abstract][Full Text] [Related]
40. The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease.
Mazier W; Saucisse N; Gatta-Cherifi B; Cota D
Trends Endocrinol Metab; 2015 Oct; 26(10):524-537. PubMed ID: 26412154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
